BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22122824)

  • 1. Suppression of aggregate formation of mutant huntingtin potentiates CREB-binding protein sequestration and apoptotic cell death.
    Choi YJ; Kim SI; Lee JW; Kwon YS; Lee HJ; Kim SS; Chun W
    Mol Cell Neurosci; 2012 Feb; 49(2):127-37. PubMed ID: 22122824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's disease--making connections.
    Greenamyre JT
    N Engl J Med; 2007 Feb; 356(5):518-20. PubMed ID: 17267914
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.
    Cong SY; Pepers BA; Evert BO; Rubinsztein DC; Roos RA; van Ommen GJ; Dorsman JC
    Mol Cell Neurosci; 2005 Dec; 30(4):560-71. PubMed ID: 16456924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRP78 counteracts cell death and protein aggregation caused by mutant huntingtin proteins.
    Jiang Y; Lv H; Liao M; Xu X; Huang S; Tan H; Peng T; Zhang Y; Li H
    Neurosci Lett; 2012 May; 516(2):182-7. PubMed ID: 22490889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
    Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
    J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
    Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin.
    Jiang H; Poirier MA; Liang Y; Pei Z; Weiskittel CE; Smith WW; DeFranco DB; Ross CA
    Neurobiol Dis; 2006 Sep; 23(3):543-51. PubMed ID: 16766198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant huntingtin represses CBP, but not p300, by binding and protein degradation.
    Cong SY; Pepers BA; Evert BO; Rubinsztein DC; Roos RA; van Ommen GJ; Dorsman JC
    Mol Cell Neurosci; 2005 Sep; 30(1):12-23. PubMed ID: 15994095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
    Banerjee M; Datta M; Bhattacharyya NP
    Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGC-1alpha, a new therapeutic target in Huntington's disease?
    McGill JK; Beal MF
    Cell; 2006 Nov; 127(3):465-8. PubMed ID: 17081970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase selectively modifies proteins associated with truncated mutant huntingtin in intact cells.
    Chun W; Lesort M; Tucholski J; Faber PW; MacDonald ME; Ross CA; Johnson GV
    Neurobiol Dis; 2001 Jun; 8(3):391-404. PubMed ID: 11442349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.
    Nucifora FC; Sasaki M; Peters MF; Huang H; Cooper JK; Yamada M; Takahashi H; Tsuji S; Troncoso J; Dawson VL; Dawson TM; Ross CA
    Science; 2001 Mar; 291(5512):2423-8. PubMed ID: 11264541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntingtin processing in pathogenesis of Huntington disease.
    Qin ZH; Gu ZL
    Acta Pharmacol Sin; 2004 Oct; 25(10):1243-9. PubMed ID: 15456523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3zeta is indispensable for aggregate formation of polyglutamine-expanded huntingtin protein.
    Omi K; Hachiya NS; Tanaka M; Tokunaga K; Kaneko K
    Neurosci Lett; 2008 Jan; 431(1):45-50. PubMed ID: 18078716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue transglutaminase does not contribute to the formation of mutant huntingtin aggregates.
    Chun W; Lesort M; Tucholski J; Ross CA; Johnson GV
    J Cell Biol; 2001 Apr; 153(1):25-34. PubMed ID: 11285271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
    Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
    Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction.
    Goswami A; Dikshit P; Mishra A; Mulherkar S; Nukina N; Jana NR
    Biochem Biophys Res Commun; 2006 Mar; 342(1):184-90. PubMed ID: 16472774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model.
    Weiss KR; Kimura Y; Lee WC; Littleton JT
    Genetics; 2012 Feb; 190(2):581-600. PubMed ID: 22095086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.
    Reijonen S; Putkonen N; Nørremølle A; Lindholm D; Korhonen L
    Exp Cell Res; 2008 Mar; 314(5):950-60. PubMed ID: 18255062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense downregulation of mutant huntingtin in a cell model.
    Hasholt L; Abell K; Nørremølle A; Nellemann C; Fenger K; Sørensen SA
    J Gene Med; 2003 Jun; 5(6):528-38. PubMed ID: 12797118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.